Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438410 · ClinicalTrials.gov registry record
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 13
- Enrollment target
NCT02438410: Completed study, sponsored by Mayo Clinic.
NCT02438410 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02438410 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
To assess if infliximab drug levels in subjects with Ulcerative Colitis predict risk of colectomy rate. Additionally, the investigators will estimate an optimal day 4 infliximab level based on the study results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438410
The ClinicalTrials.gov registry entry for NCT02438410 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02438410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438410 about?
NCT02438410 is a clinical study titled "Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis". To assess if infliximab drug levels in subjects with Ulcerative Colitis predict risk of colectomy rate. Additionally, the investigators will estimate an optimal day 4 infliximab level based on the study results.
What is the current status of trial NCT02438410?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-05. Estimated completion is 2019-12-04.
Who is sponsoring clinical trial NCT02438410?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.